Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas
Open Access
- 21 January 2026
- journal article
- abstracts
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (1) , e0340183
Abstract
Neurofibromatosis type 1 (NF1) is an autosomal dominant condition in which patients are heterozygous for a disruptive pathogenic variant in the NF1 gene. The most characteristic feature of the condition NF1 is the neurofibroma, a benign, multi-cellular tumor which initiates when a cell of the Schwann cell lineage gains a somatic pathogenic variant of the other NF1 allele. Neurofibromas developing at nerve termini in the skin are termed “cutaneous” neurofibromas (cNFs), while those developing within larger nerves are termed “plexiform.” Most patients develop cNFs beginning in late childhood or early adulthood, continuing throughout life at variable rates. Some patients may develop only a few cNFs, while others suffer from thousands. There are no reliably effective physical or pharmaceutical therapies besides surgical removal. Although these are not life-threatening, they are disfiguring and can interfere with normal life functions. To provide a resource for research, we developed short-term cNF Schwann cell cultures from NF1 patients, from which we subsequently established the first semi-immortalized cNF cell lines through transduction with wild-type human telomerase reverse transcriptase ( hTERT ) and murine cyclin-dependent kinase 4 ( mCdk4 ) genes. Here we present molecular, cellular, and functional characterization of these cell lines, which will be of utility for investigating and developing NF1 cNF therapies.Keywords
All Related Versions
Funding Information
- Neurofibromatosis Therapeutic Acceleration Program (185709)
- Gilbert Family Foundation
- Neurofibromatosis Therapeutic Acceleration Program (185708)
- Neurofibromatosis Therapeutic Acceleration Program (229103)
- Neurofibromatosis Therapeutic Acceleration Program (229103)
- Division of Cancer Epidemiology and Genetics (Z01CP010144-18)
- Division of Cancer Epidemiology and Genetics (Z01CP010144-18)
This publication has 68 references indexed in Scilit:
- Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1Molecular Therapy Nucleic Acids, 2023
- Targeted exon skipping of NF1 exon 17 as a therapeutic for neurofibromatosis type IMolecular Therapy Nucleic Acids, 2022
- Analysis of patient‐specific NF1 variants leads to functional insights for Ras signaling that can impact personalized medicineHuman Mutation, 2021
- Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screeningExperimental Neurology, 2018
- Decoding mechanisms by which silent codon changes influence protein biogenesis and functionThe International Journal of Biochemistry & Cell Biology, 2015
- Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register serviceAmerican Journal of Medical Genetics Part A, 2010
- Lentiviral Vector Transduction of Dendritic Cells for Novel Vaccine Strategies2009
- In vitro studies of steroid hormones in neurofibromatosis 1 tumors and schwann cellsMolecular Carcinogenesis, 2007
- Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expressionClinical & Experimental Metastasis, 1995
- Cell culture studies on neurofibromatosis (von Recklinghausen). II. Occurrence of glial cells in primary cultures of peripheral neurofibromasHuman Genetics, 1983